ABN Newswire

RCG Holdings Limited (HKG:0802)(LON:RCG) Unbreakable Growth

newsroom@abnnewswire.net — Tue, 24 Mar 2009 09:56:36 GMT

RCG Holdings Limited (HKG:0802)(LON:RCG) has a record breaking performance and growth prospect in its industry. Despite the financial turmoil, the company continue to record growth in company equity and EPS. The company has a turnover of HKD $2,002 million in FY 2008 representing a whopping 4,348% growth over the last 5 years.

Dr Raymond Chu suggests that the company is highly customer focus and has devoted a lot of resources in developing its sales and distribution network to meet the needs of the market. That customer focus mentality differentiates his company from the rest of the competitors.

The company made a wise decision to venture into China and establish its present in China about 2 years ago. China, as one of the largest growing economies in the world today, has proven to be a success for the company by driving new long term contracts to the company.

The company has worked closely with the two largest banks in China, namely the Bank of China and Construction Bank of China in development and implementation of RFID Asset management solution and RFID VIP identification solution. Further to their success in providing solution base projects to large enterprises, the company also succeed in winning long term contracts from the Chinese government since 2007.

The company secured numerous contracts from government backed projects including stadium operations, hospital RFID and Containers Ports.

In 2009, the company will continue its development in South East Asia and also from the Middle East Region, including operations in Dubai, Qatar, Jordan and Oman.

RCG was a dual listed company. RCG was listed in the London AIM market in 2004 and also listed in the Hong Kong Main Board as of the 1st Quarter of 2009

About Dr Raymond Chu

Dr Raymond Chu is the founder of RCG Holdings Limited. He is also the CEO and the chairman of the company responsible for the group’s global business development, operation and management. Before starting his company in 1999, Dr Raymond Chu is a well respected lawyer in HK. He was graduated from the University of Bristol, England in 1984 and was admitted as a solicitor in HK in 1987.

Investor Relations Department
Tel: +852-3669-6999
Fax: +852-3669-6888
Email: ir@rcg.tv
Website: http://www.rcg.tv

OMRON Introduces New EPC UHF Global Reader Platform; Enables High Performance Reading/Writing Under a Wide Range of Conditions and RFID Applications in Three Major Regions of the Globe

newsroom@abnnewswire.net — Wed, 2 Aug 2006 14:41:18 GMT

OMRON Corporation (TSE: 6645; US: OMRNY) today announced its new V750 reader platform, which will support global frequency bands for the United States (915MHz), Europe (867MHz) and Japan (953MHz). The V750 series, designed and manufactured by OMRON, will be newly introduced to the European and Japanese markets, while in the U.S. it represents an expansion to OMRON's current V740 EPC UHF reader product range.

The V750 reader platform enables high performance EPC Gen2 reading/writing and features easy set up, advanced diagnostics, self execution and RF environmental monitoring functions.

Drawing on decades of experience in the design and manufacturing of RFID systems, OMRON has introduced the V750 in response to many global customer and system integrator requests for an interrogator that can lower total installation costs, expand RFID applications and provide site analysis assistance.

The V750 runs on a light real-time operating system (RTOS) that delivers consistent, repeatable performance to meet high-line speed and I/O requirements for supply chain as well as packaging and manufacturing operations. For example, the V750 has an "optimized" implementation for tag density self adjustment which improves actual read times required for applications that have frequent changes to the number of tags being read.

The new platform supports OMRON's recently announced scanning antenna technology that provides direction of tag travel and eliminates "null points" in the read zone to achieve significant improvement for RFID tag read reliability.

The combination of OMRON's global frequency Gen2 inlays and the new V750 reader platform continues to underscore and expand the company's commitment to support today's worldwide business activities.

-----------------------------------------------------------------------
Item                                 Specifications
-----------------------------------------------------------------------
Communication specification	
-----------------------------------------------------------------------
Frequencies    V750-BA50C04-US       USA: 902M-928MHz (50ch, FHSS)
               V750-BA50C04-EU       Europe: 865.6M-867.6MHz (10ch,LBT)
               V750-BA50C04-JP       Japan: 952M-954MHz (9ch,LBT)

Supported Tag                        EPC Class1 Generation2

Antenna                              4 Mono-Static
-----------------------------------------------------------------------
Structure / Environmentability
-----------------------------------------------------------------------	
Operating temperature                -10 to +50C

Protection Class                     IP50

Power supply                         Via attached AC Adopter (DC12V)

Dimensions                           246 x 215 x 43.5 mm

Mounting 	                            4 point screw
-----------------------------------------------------------------------
System interface
-----------------------------------------------------------------------
Control Port                         10/100Base-T Ethernet(RJ-45)
                                     RS-232C(DB9)

Digital I/O                          4 Input/ 4 Output

LED Indicator                        8 Operation status
                                     8 I/O Status

Control Method                       V750 Original Command/Response

Scalability                          1.Software Upgradeable
                                     2.Antenna Control Port (R.F.U.)
-----------------------------------------------------------------------

In the U.S.: 
Dave Reiners, for Omron RFID
Office: 847-279-0022, ext. 233
Cellular: 224-612-0167
e-mail: dave.reiners@techimage.com

Outside the U.S.: 
James Seddon
OMRON Corporation, Corporate Brand Communications Dept. (Tokyo, Japan)
Phone: +81-3-3436-7202  
Fax: +81-3-3436-7029
Email: james_seddon@omron.co.jp

QRSciences Complete Spectrum San Diego Transaction

newsroom@abnnewswire.net — Wed, 22 Feb 2006 17:02:19 GMT

QRSciences (ASX: QRS) (PNK: QRSHY), a developer of advanced sensor and detection technology announced today that, through its wholly-owned subsidiary QRSciences Corporation, it has finalised a transaction for the acquisition of up to 27.4% of Spectrum San Diego Incorporated (Spectrum).

Terms of the agreement include the acquisition of preferred Spectrum stock for a combined cash and equity payment of US$2.6 million with an option to buy all the outstanding common stock on or before February 18, 2009. The Company will gain various preferential and protective rights customary for an investment of this nature including the right to appoint a nominee to the Spectrum board of directors, initially Mr. Kevin Russeth, QRSciences' Chief Executive Officer.

Spectrum is based in San Diego, California and specializes in the design and commercialisation of electronic imaging and instrumentation systems including X-ray devices for personnel and baggage screening and innovative ultra high resolution and wide field of view surveillance cameras. The group has expertise in X-ray physics, digital signal processing, X-ray sources and detectors, analogue and digital electronics and system integration.

QRSciences plan to relocate their US based staff to Spectrum's facility in San Diego.

Simon Bedford, VP Business Development of QRSciences said "Both companies share a common business model based on the development and commercialisation of cutting edge technology with cost offset through contract research, grants and outsourced engineering services. Collocation of our product development and engineering teams will drive growth through the creation of integrated devices based on the well known synergies of our existing QR, X-ray, metal detection and imaging technologies plus allow us to address a wider range of emerging opportunities from a broader combined engineering base."

Kevin Russeth, Chief Executive Officer of QRSciences added "We share many of the same government and private customers for both product sales and R&D funding and both groups are highly regarded in the security and detection industry. We feel these same customers will look on this new partnership very favourably enhancing marketing and sales efforts and creating new business opportunities in North America. The collaboration will also create economies of scale across the businesses and augment the engineering and design capability in both Australia and San Diego."

Dr. Steven Smith, President and Founder of Spectrum commented "Along with the exciting new product opportunities, QRSciences investment provides working capital for Spectrum to build its range of SentryScope surveillance products, increasing market penetration and building on the early success of over 100 units sold worldwide to date. We are also looking forward to the imminent market introduction of our CastScope X-ray equipment used for screening plaster casts and prosthetics. The CastScope was developed under funding from the US Transportation Security Administration (TSA) and is shortly to commence initial field trials at an undisclosed location in the United States."

About Spectrum:
Founded in 1998, Spectrum San Diego, Inc is a product development group specialising in the design of electronic imaging systems and instrumentation. The Company's founder and president is Dr. Steven Smith a noted expert in electronics design, X-ray imaging and Digital Signal Processing.

Spectrum's primary focus is the invention, development and commercialisation of novel imaging systems with efforts focused on two branded products, SentryScope and CastScope; and ongoing funded research and development projects.

Over the last seven years Spectrum has executed contracts and grants for the National Science Foundation, National Institute of Health, Transportation Security Administration, United States Air Force, InVision Technologies, Rapiscan Security Products and others.

For more information about Spectrum please visit: http://www.spectrumsdi.com or http://www.sentryscope.com

Warrick Hazeldine
Purple Communications
Level 3, 28 Kings Park Road,
WEST PERTH WA 6005
TEL: +61 8 9485 1254
FAX: +61 8 6263 0455
purple@purplecom.com.au

QRSciences Option Over Core Intellectual Property Portfolio

newsroom@abnnewswire.net — Mon, 6 Feb 2006 21:55:11 GMT

Advanced technology developer, QRSciences (ASX: QRS), has taken a major step in an effort to build upon its core asset by acquiring an option to purchase 14 patent families linked to the emerging technology Quadrupole Resonance (QR).

QR uses radio waves to identify the chemical composition of a range of crystalline compounds including those present in a number of explosives and narcotics.

QRS has positioned itself to become a toll-booth for QR commercialisation efforts in several key markets around the world, including the United States, Canada, Israel, the United Kingdom, Western Europe, Australia and parts of Asia.

QRS presently licenses QR technology to Rapiscan, L-3 and Lockheed Martin for use in the Homeland Security market and is in ongoing negotiations to extend licensing arrangements to other customers and commercial enterprises practicing QR in various fields.

The option agreement is with BTG International Limited (LSE: BGC), a London-based medical innovations company and QRSciences' third largest shareholder. Following an acquisition of the patents QRS would become the owner of the world's largest and most comprehensive IP portfolio in the field of QR.

Louise Makin, BTG's Chief Executive Officer, said:

"We believe QRSciences is in the best position to maximize revenues from these assets over the longer term by selling and continuing to develop products and licensing third parties."

Kevin Russeth, QRSciences' Chief Executive Officer, added:

"The BTG portfolio is a core asset in the QR landscape and ownership rights put us in a significantly stronger commercial position than we would have with similar licensing and leasing arrangements."

"The option gives QRSciences and our customers greater flexibility in the commercial marketplace and an opportunity to create a new revenue stream from licensing the BTG portfolio direct. Ultimately a value building exercise for shareholders."

Under the agreement with BTG, QRSciences will make an immediate payment of US $0.5 million and, if the option is exercised, will add 14 core patent families to its existing proprietary portfolio of 19 patents and patent applications giving it 33 patents and patent applications in total. The combined portfolio will constitute the largest and most comprehensive portfolio in this field.

Developed over the past 15 years at King's College London, BTG's 14 patent families are complementary to QRSciences' existing QR patents. In 2002, BTG granted QRSciences a worldwide exclusive license to the patents in the area of explosive and narcotic detection. QRS continues to maintain that license.

QRSciences along with General Electric's business unit, Quantum Magnetics, are the industry leaders in QR (also known as NQR and Zero-Field NMR) based explosive detection. Both organizations are actively developing commercial equipment and technology and have undergone testing and evaluation by regulators around the world including the U.S. Transportation Security Administration, an agency of the U.S. Department of Homeland Security.

Merck Sharp Dohme, AstraZeneca, Dupont, SpinLock, the U.S. Naval Research Laboratory, U.S. Department of Defence "DOD", U.K. Defence Science & Technology Laboratory "DSTL" and a handful of universities, including Penn State University and King's College London and privately funded research groups around the world in Russia, Slovenia, China and Argentina are also conducting research in the area.

QRSciences' option will expire late in the first quarter of 2006 with the remaining terms of the option arrangement remaining confidential and commercially sensitive. The Company will continue to update the market as and when developments occur.

ABOUT BTG:

BTG (LSE: BGC) acquires rights to early stage pharmaceuticals and other medical technologies from a global network of corporations, universities and research institutions. The Company applies resources including finance, intellectual property and project management skills to fund and manage outsourced pre-clinical and clinical development programs. BTG then commercialises the technologies by licensing to pharmaceutical or medical device companies, or by creating companies to exploit them. The Company is also commercialising a range of technologies in the internet and telecommunications areas. BTG's pipeline comprises around 50 assets at varying stages of development, contributing to an increasing range of products marketed by licensees. BTG operates from London, Philadelphia and Tokyo.

BTG
Andy Burrows, Director of Investor Relations
+44 (0)20 7575 1741
www.btgplc.com

Financial Dynamics
Ben Atwell
+44 (0)20 7831 3113

QRSciences Website
www.qrsciences.com

Warrick Hazeldine
Purple Communications
+61 (0) 417 944 616
+61 8 9485 1254

Keycorp Selected for Hong Kong Contactless ePassport Project

newsroom@abnnewswire.net — Tue, 24 Jan 2006 10:31:55 GMT

Secure electronic transaction solutions provider Keycorp Limited (ASX: KYC) today announced it had been selected as the exclusive supplier of MULTOS technology to the consortium awarded the tender for ePASS, Hong Kong's ePassport project.

It is the first win for Keycorp's MULTOS ePassport solution, which was launched in November 2005 at the Cartes smartcards trade show in Paris.

Hong Kong Immigration Department awarded a tender for ePASS to Unihub Limited, which is heading a consortium of suppliers, including Keycorp, who will develop and deliver the new ePassport system.

The project is due to commence in 2006.

The Keycorp MULTOS ePassport technology capitalises on the special features that have made MULTOS the most secure, open, multi-application smartcard operating system.

The MULTOS technology is recognised as a leading open platform smartcard solution for banking and ID, where security and flexibility is a critical requirement. Keycorp is the leading supplier of MULTOS products, recently selected for the Turkish military ID project.

Jeffery Bird
Bird & Hill Public Relations 
Suite 3, Level 5 
132 Arthur Street 
North Sydney NSW 2060 
TEL: +61 2 9954 0555

QRSCIENCES Announce Half Year Revenue Up 247%

newsroom@abnnewswire.net — Wed, 11 Jan 2006 11:03:43 GMT

QRSciences (QRS: ASX) (QRSHY: PK), a developer of advanced sensing technologies today announced the company's half yearly revenue increased from $ 375,000 to approximately A$ 1,300,000 (up 247%) over the corresponding period last year.

"Our expectation is that there will be a continued upward trend in revenue growth in the short to mid term, reflecting a very interesting growth stock opportunity for investors." said QRSciences CEO, Mr. Kevin Russeth.

This year should be a banner year for the company as its two technologies begin selling in the market. Combined with strong growth from contract R&D and consulting, on top of the synergies that the company will realise from its investment in Spectrum San Diego and its distribution relationship with XTEK, it is well positioned for solid and continued growth.

"The number one priority to grow shareholder value in 2006 is revenue," added Mr. Russeth.

"Success for us this year will be measured in the culmination and delivery of a number of proposed sales, research contracts and licensing proposals that the company is currently progressing around the world." Mr. Russeth concluded.

Jennifer Zimmons
Strategic Growth
New York, N.Y.
Tel: +1(212)838-1444


Warrick Hazeldine
Purple Communications
Perth, Australia
Tel: + 61 (0) 8 9485 1254
Mob: +61 (0) 417 944 616


Kevin Russeth
QRSciences
San Diego, CA
Tel: +1(858)345-1095
Australia: +61 (0) 8 9351 1200